Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. | Breast Cancer Res Treat | 2023 | 37002487 | PubTator, text mining | PubMed |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. | Cancer Med | 2023 | 36999792 | PubTator, text mining | PubMed |
| HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer. | Mol Cancer | 2023 | 36997931 | PubTator, text mining | PubMed |
| CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion. | bioRxiv | 2023 | 36993615 | PubTator, text mining | PubMed |
| Therapeutic Potential of Luteolin on Cancer. | Vaccines (Basel) | 2023 | 36992138 | PubTator, text mining | PubMed |
| The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases. | Drug Resist Updat | 2023 | 36990046 | PubTator, text mining | PubMed |
| [Clinical characteristics and prognosis of primary and secondary diffuse large B-cell lymphoma of the pancreas]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 36987724 | PubTator, text mining | PubMed |
| The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer. | Int J Mol Sci | 2023 | 36982838 | PubTator, text mining | PubMed |
| Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review. | Cancers (Basel) | 2023 | 36980718 | PubTator, text mining | PubMed |
| Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications. | Cancers (Basel) | 2023 | 36980614 | PubTator, text mining | PubMed |
| Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy. | Cancers (Basel) | 2023 | 36980613 | PubTator, text mining | PubMed |
| Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines. | Cells | 2023 | 36980177 | PubTator, text mining | PubMed |
| Telomere Transcription in MLL-Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy. | Biomedicines | 2023 | 36979904 | PubTator, text mining | PubMed |
| PDE3A and GSK3B as Atrial Fibrillation Susceptibility Genes in the Chinese Population via Bioinformatics and Genome-Wide Association Analysis. | Biomedicines | 2023 | 36979891 | PubTator, text mining | PubMed |
| Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation. | Biomolecules | 2023 | 36979456 | PubTator, text mining | PubMed |
| Anal Cancer: The Past, Present and Future. | Curr Oncol | 2023 | 36975459 | PubTator, text mining | PubMed |
| Pulmonary arterial hypertension associated with congenital heart disease: An omics study. | Front Cardiovasc Med | 2023 | 36970344 | PubTator, text mining | PubMed |
| Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. | Front Oncol | 2023 | 36969007 | PubTator, text mining | PubMed |
| Epigenetics and immune cells in medulloblastoma. | Front Genet | 2023 | 36968588 | PubTator, text mining | PubMed |
| Editorial: Identification of New Molecular Mechanisms of Bone Disease, volume II. | Front Cell Dev Biol | 2023 | 36960412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=36